RxDoctor Payments Data

Timothy Long, MD

Family Medicine · Bowling Green, KYNPI 1699743567

Payments from drug & device makers

$448in general payments, 2019–2025

Across 26 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$126
  • Amgen$59
  • Lilly USA, LLC$39
  • Pfizer$39
  • Novo Nordisk$36
  • Esperion Therapeutics, Inc.$29
  • plus $120 from 6 others

What the payments were for

  • Food & beverage$35680%
  • Education$9220%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$448 in reported general payments places this provider in the 40th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$393,584
Medicare patients
635
Services billed
10,631

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban81$86,859
JardianceEmpagliflozin79$84,845
MounjaroTirzepatide50$73,467
TrulicityDulaglutide45$60,969
OzempicSemaglutide51$60,435
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$28,231
JanuviaSitagliptin Phosphate23$16,826
Soliqua 100-33Insulin Glargine/Lixisenatide15$13,007
Repatha SyringeEvolocumab20$11,831
Lantus SolostarInsulin Glargine,hum.Rec.Anlog55$11,168
EntrestoSacubitril/Valsartan15$10,622
BrilintaTicagrelor17$9,597
CreonLipase/Protease/Amylase14$9,011
SymbicortBudesonide/Formoterol Fumarate16$7,960
LinzessLinaclotide13$6,814

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$39$134,43695 claims
PfizerEliquis$39$86,85981 claims
Novo NordiskOzempic$36$60,43551 claims
GSKTrelegy Ellipta$29$28,23121 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$12$13,00715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →